Home > AACR Cancer Progress Report > AACR Cancer Progress Report 2019: Contents
In the United States, the overall cancer death rate is decreasing, and the number of cancer survivors is increasing. In the past 3 years, the number of cancer survivors living in the United States increased by 1.4 million, reaching more than 16.9 million on January 1, 2019. Since the...
In this section, you will learn: Over the past few decades, we have made tremendous progress in preventing, detecting, diagnosing, and treating cancer. This progress is epitomized by the declining overall cancer death rate and the rising number of cancer survivors (see Research: Driving Progress against Cancer). It has...
In this section, you will learn: In the United States, the overall cancer death rate has been declining steadily over the past two decades, and the number of individuals living with a history of cancer has reached a record high. However, even in 2019, an estimated 606,880 people will...
In this section, you will learn: Research that increases our understanding of the genetic, molecular, and cellular characteristics of cancer is continuing to spur advances in the treatment of cancer. Advances are being made across all five pillars of cancer care: surgery, radiation, cytotoxic chemotherapy, molecularly targeted therapy, and...
In this section, you will learn: Research identifying how cancer arises and progresses has led to the development of screening tests that can be used for early detection of cancer and precancerous lesions. There are four types of cancer (breast, cervical, colorectal, and prostate) for which screening tests have...
In this section, you will learn: In the United States, the number of people living with a history of cancer is expected to rise by 5.2 million in the next 11 years, reaching 22.1 million by January 1, 2030. Each person diagnosed with cancer faces a unique set of...
In this section you will learn: Innovations in cancer research through interdisciplinary team science approaches will help shape the future of patient care. Integration and mining of health care data from various sources will allow researchers to gain more insights into cancer biology and thereby improve patient outcomes. Cutting-edge...
In this section you will learn: Federal funding for medical research, most specifically through NIH and NCI, has a significant impact on our nation’s health and the United States economy. Regulatory science initiatives at the FDA are vital to accelerating progress against cancer. Policies and federally funded public health...
Research is driving progress against cancer because it is the foundation of every lifesaving clinical advance and every new policy designed to improve the health of the nation. The remarkable advances are illustrated by the declining cancer death rates and the rising number of children and adults who survive...
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Today